HLA-A*0201 Positive Cells Present
Drug | Drug Name | Drug Description |
---|---|---|
DB15283 | Tebentafusp | A bispecific gp100 peptide-HLA-directed CD3 T cell engager used to treat unresectable or metastatic uveal melanoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB15283 | Tebentafusp | Melanocyte protein PMEL | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00041 | Aldesleukin | 1 | Completed | 1 |
DB00041 | Aldesleukin | 1 | Terminated | 1 |
DB00041 | Aldesleukin | 1 | Withdrawn | 1 |
DB01008 | Busulfan | 1 | Terminated | 1 |
DB00531 | Cyclophosphamide | 1 | Completed | 1 |
DB00099 | Filgrastim | 1 | Terminated | 1 |
DB00099 | Filgrastim | 1 | Withdrawn | 1 |
DB01073 | Fludarabine | 1 | Terminated | 1 |
DB17288 | LV305 | 1 | Completed | 1 |
DB00480 | Lenalidomide | 1 | Withdrawn | 1 |
DB00888 | Mechlorethamine | 1 | Withdrawn | 1 |
DB06809 | Plerixafor | 1 | Terminated | 1 |
DB06809 | Plerixafor | 1 | Withdrawn | 1 |
DB00041 | Aldesleukin | 1 / 2 | Completed | 1 |
DB00041 | Aldesleukin | 1 / 2 | Terminated | 3 |
DB00531 | Cyclophosphamide | 1 / 2 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Terminated | 2 |
DB01073 | Fludarabine | 1 / 2 | Terminated | 1 |
DB15113 | Utomilumab | 1 / 2 | Completed | 1 |